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Background: Airway-centered Interstitial Fibrosis (ACIF) is a common pathologic pattern observed in our practice.
Objectives: The objectives of this study are to describe the causes associated with ACIF in a large sample of patients and
its effect on survival.
Methods: A retrospective study in three centers of interstitial lung disease in São Paulo, between January of 1995 and
December of 2012. The surgical lung biopsy specimens were reviewed by three pathologists. The clinical, functional and
tomographic findings were analyzed by a standardized protocol.
Results: There were 68 cases of ACIF, most of them women. The mean age was 57 ± 12 yr. Dyspnea, cough, restrictive
pattern at spirometry and oxygen desaturation at exercise were common. A reticular pattern with peribronchovascular
infiltrates was found in 79% of the cases. The etiologies of ACIF were hypersensitivity pneumonitis in 29 (42.6%),
gastroesophageal reflux disease in 17 (25.0%), collagen vascular disease in 4 (5.9%), a combination of them in 15
cases and idiopathic in 3 (4.4%). The median survival was 116 months (95% CI = 58.5 – 173.5). Lower values of
oxygen saturation at rest, presence of cough and some histological findings - organizing tissue in the airways, fibroblastic
foci and microscopic honeycombing - were predictors of worse survival.
Conclusions: ACIF is an interstitial lung disease with a better survival when compared with IPF. The main etiologies are
HP and GERD. The oxygen saturation at rest, the presence of cough and some histological findings are predictors of
survival.
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Since 2002 a new interstitial pneumonia centered on small
airways and no granulomas has been described in small
series [1-4]. This entity has been variably called centrilobu-
lar fibrosis, bronchiolocentric interstitial pneumonia,
airway-centered interstitial fibrosis, and peribronchiolar
metaplasia [3-6]. Lung biopsies from these cases showed a
distinctive pattern of interstitial fibrosis centered and ex-
tending around the bronchioles, often with bronchiolar
metaplasia of the epithelium. Due to involvement of small
as well large airways [5,7], the best name seems to be
airway-centered interstitial fibrosis (ACIF). The prognosis is
unknown due to small number of cases described [2-4].
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unless otherwise stated.findings have been described in hypersensitivity pneumon-
itis (HP) [8-15] or be secondary to gastroesophageal reflux
disease (GERD), isolated or associated with connective tis-
sue diseases [16,17]. In our clinical practice this pathologic
pattern is common in multidisciplinary case discussions.
The objectives of the present study were to describe
the causes, the clinical, tomographic, functional and
pathologic findings and their influence on survival in a
large number of patients with histologic diagnosis of
airway-centered interstitial fibrosis.Material and methods
Selection of cases
A retrospective cohort of 68 adult patients with ACIF
was evaluated. The medical records of 2716 patients
with interstitial lung diseases, seen between January of
1995 and December of 2012 at three facilities in the cityal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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600 patients were submitted to surgical lung biopsies.
Cases with any findings of possible ACIF or describing
bronchiolar involvement without a specific diagnosis of
bronchiolitis were reevaluated. In this database, 115 pa-
tients had a diagnosis of possible ACIF by surgical lung
biopsy. From this sample, 36 cases were excluded due to
a another diagnosis after a review of the slides (mainly
bronchiolitis, characterized by bronchiolar inflammation
and/or fibrosis in the absence of peribronchiolar involve-
ment as well absence of reticular pattern on HRCT); six
cases were excluded due to incomplete data and five due
to honeycombing (an exclusion criteria due to possible
non representative biopsies in advanced disease) ob-
served on a HRCT scan. None of the patients died after
lung biopsy. Biopsies were done by small thoracotomies
or VATS, involving one or more sites, but this informa-
tion was not available in final analysis. The final sample
comprised 68 patients.
This study was approved by ethics committee of the
Federal University of São Paulo (register number 2079-09).
Histological findings
Patients were selected primarily by a revision of lung
biopsies by two pathologists dedicated to lung pathology,
and with a large experience in interstitial lung disease
(ILD). The cases were selected initially by one of them
and 48 of them were sent to KOL for confirmation. He
agreed with diagnoses and described and classified the
findings in each case. The remaining twenty cases were
diagnosed by consensus between our two pathologists,
who also followed the same classification of findings.
Concordance by kappa was not calculated. The diagnosis
was based on previously suggested criteria [4-6]. The
main diagnostic criteria included a fibrosis predomin-
antly bronchiolocentric associated with bronchiolar or
peribronchiolar inflammation and peribronchiolar meta-
plasia. Cases with granulomas and foreign material were
excluded. Incidental findings like such as fibromyxoid
tissue foci in airways, fibroblastic foci, honeycombing,
giant cells, cholesterol clefts, respiratory bronchiolitis,
features of acute injury (tissue edema and the presence
of fibrin), and focal areas of heterogeneous or homoge-
neous fibrosis (usual interstitial pneumonia (UIP) and
nod-specific interstitial pneumonia (NSIP) like, respect-
ively) were recorded.
Clinical analysis and HRCT
A standardized protocol for investigation of interstitial
lung diseases was used for all patients. Dyspnoea was
assessed by Magnitude of Task of Basal Dyspnea Index
(BDI) [18]. Total BDI score was not considered because
functional impairment and magnitude of effort do not
involve the same activities in different patients. The datarelated to environmental exposures were recorded. A
diagnosis of HP was based on the exposure and the ab-
sence of other potential causes of ACIF. Precipitins tests
and cellular analysis of bronchoalveolar lavage were not
available. Possible connective tissue disease (CTD) was
investigated by clinical and complementary tests in all
cases. The diagnostic criteria for CTD were those previ-
ously described [19].
Symptoms of GERD (heartburn, regurgitation) were
recorded in all cases. An ambulatory 24-hour esophageal
pH measurement with a dual sensor was performed ac-
cording to standardized techniques [20]. The diagnostic
criteria for an abnormal proximal [21] and distal [22]
reflux have been previously described.
After biopsies selection, the final clinical diagnoses were
retrospectively determined by multidisciplinary discussion.
The diagnoses were classified as HP, GERD, CTD, a com-
bination of two or more categories or idiopathic.
Pulmonary function tests were conducted according to
the American Thoracic Society guidelines [23]. The nor-
mal values for spirometry were recalculated according
2007 values derived for the Brazilian population [24].
Normal values for DLco were from Crapo [25]. The per-
ipheral oxygen saturation was evaluated at rest and after
a 4-minute self-paced step test [26].
All CT scans were read by experienced radiologists
and pulmonologists through a systematic analysis of the
findings. The final findings were selected by consensus.
Scores for extension of disease were not calculated. Ex-
piratory views were not done systematically.
The drugs used for at least three months for ACIF and
GERD treatment were recorded. Antigen avoidance and
abatement procedures were recommended when expos-
ure was present.Survival
Survival was assessed from the day of the biopsy through
December 2012. Deaths were identified by a follow-up con-
tact or through telephone notification by relatives. Deaths
were considered ACIF-related if they were due to respira-
tory failure, pneumonia or pulmonary fibrosis. One patient
was censored at the time of lung transplantation.Statistical analysis
All of the data analyses were performed using the SPSS
program, version 19. According distribution, data were
expressed as mean ± SD, or as median and range. The con-
tinuous data with a normal distribution were compared
using t-tests. A chi-square test was used for comparisons of
proportions. The impact of clinical, functional, tomographic
and pathologic data on survival was calculated by univariate
Cox regression ant by Kaplan-Meyer curves. Two-sided
p values <0.05 were considered to be statistically
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Results
The study sample comprised 68 cases, with a predomin-
ance of non-smokers, and females. The baseline charac-
teristics are shown in Table 1. The main clinical features
were cough (in 78%) and dyspnea (100%). The functional
profile was typical of diffuse restrictive lung disease, with
reduced FVC, FEV1, DLCO and a decrease of SaO2 uponTable 1 Baseline characteristics of patients with
airway-centered interstitial fibrosis (n = 68)
Characteristic Number
Sex, male/female 29/39
Age, years (mean ± SD) 57 ± 12
Duration of symptoms, in months, median (range) 24 (3–132)
Smoking
Never/ex-smoker/current smoker, n 39/28/1
Dyspnea
Major/moderate/light tasks, n 22/33/13
Coughing, n (%) 53 (78%)
Clubbing, n (%) 12 (18%)
Velcro crackles, n (%) 29 (43%)
Exposure to organic particles, n (%) 42 (62%)
Molds/birds/both 24/ 4/ 14
Gastroesophageal reflux (GERD) symptoms
None/past/current 30/ 12/ 26
Connective tissue disease (CTD), n (%)† 12 (17%)
Lung function tests
FVC, % predicted (mean ± SD) 66 ± 18
FEV1, % predicted (mean ± SD) 69 ± 18
FEV1/FVC, (mean ± SD) 0.85 ± 0,08
DLCO, % predicted (mean ± SD) (n = 43) 59 ± 17
Oxygen saturation at rest, % (mean ± SD) 94 ± 4
Oxygen saturation during exercise, % (mean ± SD) (n = 59) 87 ± 7
HRCT findings
Reticular infiltrate, n (%) 68 (100%)
Predominance: Upper lobe/lower lobe/diffuse, n 10/38/20
Predominance: Central/peripheral/both, n 9/14/45
Ground-glass opacities, n (%) 57 (84%)
Peribronchovascular, n (%) 54 (79%)
Bronchiectasis, n (%) 43 (63%)
Mosaic pattern/airtrapping, n (%) 25 (37%)
Centrilobular nodules, n (%) 14 (21%)
†Systemic sclerosis (2), Rheumatoid arthritis (3), Mixed connective tissue
disease (3), Dermatomyositis (2), Antisynthetase syndrome (1), Systemic
sclerosis and Sjögren’s syndrome (1), FEV1 = forced expiratory volume in 1 s;
FVC = forced vital capacity; DLCO =monoxide carbon lung diffusion. HRCT =
high resolution chest tomography.exercise. A reticular pattern, suggesting fibrosis, was
present in all of the cases. Central and peribronchovas-
cular distributions were seen in 79% of the cases, but an
associated peripheral distribution was common.
Exposure to birds, molds or both was present in 42 (62%)
of the cases. Current or past gastroesophageal reflux symp-
toms were reported by 56% of the cases. Ambulatory
esophageal pH monitoring was carried on in 38 cases, and
showed abnormal reflux (distal, proximal or both), in 28
(74%). In these 28 cases, past or present GERD symptoms
were absent in 6 (21.4%). There was an association between
order for ambulatory pH monitoring and reflux symptoms.
Of the 30 patients not submitted to ambulatory pH moni-
toring, only 5 (16.7%) had current symptoms of GERD,
compared with 21 (55.3%) of 38 patients submitted to pH
monitoring (x2 = 10.58, p = 0.005). Esophageal manometry
was performed in 32 patients and showed hypotonia of the
upper esophageal sphincter, esophageal body or lower
esophageal sphincter in 16 (50%).
The final clinical diagnoses are shown in Figure 1.
Hypersensitivity pneumonitis, GERD and CTD were the
most common diagnoses. In only two cases an etiology
was not apparent. The frequency of HRCT findings,
including air trapping and centrilobular nodules did not
differ between HP and GERD.
The histological findings observed are shown in
Table 2. Peribronchiolar metaplasia was present in nearly
90% of the cases. Fibroblastic foci were observed in half
of the cases. Microscopic honeycombing was found in
29% of the cases.
Images and histologic features in a representative case
of ACIF are shown in Figures 2 and 3 respectively.
The median post-biopsy follow-up period was 43.5 months.
Kaplan-Meier survival curve for all cases is shown in
Figure 4. The median survival was 116 months (95%
CI = 58.5 – 173.5). Mortality after 5 years was 32.5%. By
Cox analysis, survival was not influenced by sex, age,
dyspnea, clubbing, crackles, FVC, DLCO, exercise SaO2,
etiology and HRCT findings. Significant predictors of
greater mortality by univariate analysis (p ≤ 0.10) were
as follows: cough, lower SaO2 at rest and the presence
of organizing tissue in airways, fibroblastic foci and
microscopic honeycombing in lung biopsies (Table 3).
The patients with cough (n = 53) had a median survival
of 86 months; in those without cough (n = 15), the median
survival was undetermined (log-rank = 4.30, p = 0.039). At
the end of the follow-up, 1 of 15 (7%) patients without
cough had died compared to 19 out of 53 (36%) patients
with cough. The presence of cough was not associated with
reflux symptoms or abnormal reflux by pH monitoring
(data not shown). The patients with cough had a lower
SaO2 at rest (93.7 ± 4.4 vs 96.0 ± 2.4, t = 1.93, p = 0.058) and
at the end of exercise (85.6 ± 6.8 vs 91.3 ± 4.6, t = 3.00,
p = 0.004). The FVC was lower in the patients with
Figure 1 Clinical diagnoses of patients with airway-centered interstitial fibrosis (n = 68).
Kuranishi et al. Respiratory Research  (2015) 16:55 Page 4 of 8cough, but the difference was not significant (64.6 ±
18.2 vs 69.9 ± 20.2, p = 0.338). The patients with cough
more commonly had fibroblastic foci in lung biopsies
(58%), when compared with those without cough (20%)
(x2 = 6.93, p = 0.008).
The rest SaO2 had an influence on survival (HR for de-
creasing values 1.14, 95% CI = 1.05-1.24, p = 0.003). For
lung biopsies, the patients with microscopic honeycombing
had an unfavorable prognosis. The median survival time
was 45.0 (95% CI = 30.5-59.5) months in the 20 patients
with microscopic honeycombing, in comparison to 116.0
(95% CI = 64.6-167.4) months for the 48 patients without
honeycombing (log rank = 4.80, p = 0.028).
In the lung biopsies, a significant difference in survival
was also observed when the patients with fibroblastic foci
were compared with those without such findings. The me-
dian survival time was 74.0 (95% CI = 41.2-106.7) months
in 34 patients with fibroblastic foci, compared withTable 2 Histological findings in surgical lung biopsies
from patients with airway-centered interstitial fibrosis
(n = 68)
Major findings n (%)
Airway-centered interstitial fibrosis, n (%) 68 (100%)
Airway inflammation, n (%) 67 (98.5%)
Peribronchiolar metaplasia, n (%) 60 (88.2%)
Other findings (focal) n (%)
Organizing tissue in airways, n (%) 25 (36.8%)
Giant cells, n (%) 12 (17.6%)
Interstitial heterogeneous fibrosis, n (%) 18 (26.5%)
Interstitial homogeneous fibrosis, n (%) 32 (47.1%)
Fibroblastic foci, n (%) 34 (50.0%)
Microscopic honeycombing, n (%) 20 (29.4%)116.0 months (95% CI = 58.5-173.5) in the 34 patients
without fibroblastic foci (log rank = 5.98, p = 0.014).
The patients who had organizing tissue present in the
airways had also a worse prognosis. The median survival
time was 74.0 (95% CI = 23.8-124.1) months in 25 patients
with organizing tissue in the airways, compared with
116.0 months (95% CI = 59.6-172.4) in the 43 patients
without organizing tissue in airways (log rank = 4.80,
p = 0.028).
Isolated giant cells were found in 12 cases - 4 with HP,
5 with aspiration, 2 with CTD and 1 with a combination
of etiologies. Antigen avoidance and abatement proce-
dures were recommended for all cases exposed to or-
ganic particles. GERD treatment was prescribed for all
patients with abnormal in pH monitoring results or with
current reflux symptoms. Pharmacological treatment
was prescribed in 53 cases - corticosteroids in 23, iso-
lated immunossupressor in 1, and both corticosteroids
and immunossupressors in 29. The effect of these treat-
ments on survival was uncertain.
Discussion
The present study describes 68 patients with bronchiolo-
centric interstitial fibrosis. Hypersensitivity pneumonitis
and GERD were the most common etiologies. The me-
dian survival was approximately 10 years but could be
better predicted by histological findings.
In 2002 Yousem and Dacic [4] reported 10 patients
with fibrosis and inflammatory process centered in
small airways. In 2004, Churg et al. [5] described 12 pa-
tients with a more severe small bronchiolocentric intersti-
tial fibrosis. Metaplastic bronchiolar epithelium extending
around the bronchioles was described in both studies
[4,5]. Because there was radiographic evidence of fibro-
sis around the large airways and microscopic evidence
Figure 2 Radiologic findings of a patient with ACIF, showing diffuse ground glass opacities on peribronchovascular region, reticular infiltrates
and traction bronchiectasias.
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this condition “Airway-centered Interstitial Fibrosis.
Fukuoka et al. [6] described a histological pattern char-
acterized essentially by the presence of peribronchiolar
metaplasia in 15 patients.Figure 3 Histologic features of airway-centered interstitial fibrosis. (A) Air
centrilobular fibrosis from figure a. (C) Peribronchiolar alveolar metaplasia
organization on airways.Based on these studies, we selected the presence of
bronchiolar-centered interstitial fibrosis, bronchiolar/peri-
bronchiolar inflammation and peribronchiolar metaplasia
as the major criteria for ACIF diagnosis. Peribronchiolar
metaplasia is an incidental finding observed in a variety ofway-centered fibrosis with obliteration of bronchioles, (B) a detailed
. (D) Inflammatory peribronchiolar infiltration, obliterative focal
Figure 4 Kaplan-Meier survival curve for patients with airway-centered interstitial fibrosis (n = 68); median survival = 116 months (95% CI = 58.5 - 173.5).
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findings indicative of other interstitial lung diseases are ab-
sent. There was no association between peribronchiolar
metaplasia and smoking (data not shown).
The lesions centered in the airways suggest an injury due
to inhalation or aspiration. In HRCT, peribronchial intersti-
tial thickening and signs of bronchiolar involvement are
consistent with this hypothesis. In our series, exposure to
birds, molds or both at home, were common. Chronic
interstitial pneumonia, bronchiolitis and a distinctive form
of peribronchiolar granulomatous inflammation is the most
frequent combination of findings in surgical lung biopsies
from patients with a clinical diagnosis of HP [27], but
granulomas can be absent, especially in chronic disease
[8,9]. ACIF has been described in a subset of patients inTable 3 Univariate Cox analysis for significant survival
predictor variables (p < 0.10) in patients with airway-
centered interstitial fibrosis (n = 68)
Variable HR 95% CI p
Cough 6.45 0.85-47.6 0.071
Oxygen saturation at rest 1.14 1.04-1.24 0.003
Organizing airway tissue 2.71 1.10-6.67 0.029
Fibroblastic foci 3.32 1.19-9.26 0.021
Microscopic honeycombing 2.76 1.07-7.14 0.036small series and case reports of HP [7-10] and in case
reports in which birds and molds have been well docu-
mented as the etiology [7,12-14]. Studies made in Japan
have clearly shown that bronchiolocentric interstitial
fibrosis is a common pathologic expression of chronic
hypersensitivity pneumonitis [28-30]. Fibroblastic foci, hon-
eycombing and organizing pneumonia were common.
Granulomas were absent in many cases [28,29]. Bridging
fibrosis between respiratory bronchioles and adjacent sub-
pleural or intralobular septa seems to be a distinctive fea-
ture [28,29], but in our study this was not evaluated.
The aspiration of large volumes of gastric content to
the lungs can result in several patterns of injury [31].
Inflammation, scarring and bronchiolar metaplasia in
the centrilobular zones of the lung were identified in
cases of chronic aspiration in humans [16] and in an
experimental model [32]. Microaspiration of the gastric
contents has been extensively evaluated in patients with
IPF and in systemic sclerosis and other CTDs [31]. In
scleroderma, a disease in which GERD is common, cen-
trilobular fibrosis was described in 21% of 28 lung bi-
opsies [17].
Chronic HP can result several histological patterns, in-
cluding NSIP and an UIP-like pattern [8,9,15,28,33]. The
findings of giant cells or granulomas in these cases could
suggest the presence of HP. The presence of giant cells
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to HP. Patients with granulomas were excluded from
our study. Fibroblastic foci and honeycombing are both
common in UIP, but can also be found in chronic HP
[15,28,29,10,11]. IPF is a disease of older males, whereas
ACIF predominates in women with a lower mean age.
The prognosis of IPF is dire, with a median survival of
4 years after the diagnosis [34]. In our study, the median
survival was 10 years, but when honeycomb changes
were present in biopsies, the median survival was
45 months. The presence of fibroblastic foci was also
predictive of worse survival, a finding similar to IPF [35].
Some conditions can result in bronchiolocentric le-
sions associated with fibrosis. A smoking-related fibro-
sis has been described under different names and a
bronchiolocentric fibrosis can be observed [36,37]. In
our study, as expected, focal respiratory bronchiolitis
was found in some smokers, but other findings of
smoking-related interstitial fibrosis were absent. ACIF
could represent a late stage of a preexisting obliterans
organizing pneumonia. Organizing tissue in airways
was seen in 37% of our cases, but focal organizing
pneumonia was seen in only one case, diagnosed as
chronic hypersensitivity pneumonitis.
From a morphologic perspective, bronchiolocentric
interstitial pneumonia needs to be separated from bron-
chiolitis [4]. In fact, several cases diagnosed as possible
ACIF were excluded after review of slides and HRCT.
Absence of peribronchiolar parenchymal lesions in biop-
sies and presence of diffuse reticular opacities on HRCT
were major findings in differential diagnosis. Katzenstein
et al. reported cases of nonspecific interstitial pneumo-
nia with a bronchiolocentric distribution; however, sev-
eral cases had relevant exposure and giant cells in
biopsies [38]. Bronchiolocentricity of inflammation or
fibrosis was seen in 9 (13.4%) cases in Travis et al. series
of non-specific interstitial pneumonia, but when present
it was not a dominant feature [39]. In the present study,
bronchiolocentric lesions were dominant, and when
present, areas of uniform fibrosis were focal.
In the recent ATS/ERS update on IIP classification,
ACIF was not included because of questions concerning
whether they are variants of existing IIPs or exist only in
association with other conditions such as HP or CTD
[40]. In our series, only two were considered to be
idiopathic.
There are several limitations in our study. It was
retrospective; although gold standards tests for the
diagnosis of aspiration are not available, esophageal pH
measurements were not performed in all cases. The
diagnosis of HP was based on environmental exposures
only. BAL cell count and precipitins were not available.
A recent study from Japan on chronic HP found centri-
lobular fibrosis as the major pathologic finding inchronic HP. Elevated lymphocytes in BAL were absent
in many cases [30].
In our study, agreement between readers of pathologic
slides and HRCT scans was not examined. Five patients
with honeycombing at HRCT were excluded, but 29% of
cases had microscopic honeycombing. The cases ex-
cluded had etiology similar to those included. Extent of
lung fibrosis on the baseline CT is predictive of survival
in chronic HP [41], but extent of fibrosis on HRCT in
our study was not evaluated. Finally, the influence of
antigen avoidance, reflux treatment, and use de anti-
inflammatory drugs on survival is unknown.
In conclusion, ACIF is common in HP, but can be
found in other settings, especially microaspiration. Idio-
pathic disease is rare. The prognosis is more favorable
than that published for IPF, but is reduced in patients
with cough and in those patients with biopsies showing
fibroblastic foci or organizing tissue in the airways, and
especially when microscopic honeycombing is present.
Abbreviation
ACIF: Airway-centered interstitial fibrosis; IPF: Idiopathic pulmonary fibrosis;
HP: Hypersensitivity pneumonia; GERD: Gastroesophageal reflux disease;
HRCT: High resolution computerized tomography; VATS: Video-assited
thoracic surgery; ILD: Interstitial lung disease; UIP: Usual interstitial
pneumonia; NSIP: Non-specific interstitial pneumonia; BDI: Basal dyspnea
index; CTD: Connective tissue disease; BAL: Bronchoalveolar lavage.
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